Results

• All
• Video
• Audio
• Images

• Most recent

1–3 of 3 results for gene agnostic

• 

  One Year Follow-up in a Phase 1/2 Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa

  Benjamin Bakall, MD, PhD

  Annual Meeting Talks

  2024

• 

  One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa

  Benjamin Bakall, MD, PhD

  Updates from the Field

  2024

• 

  BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)

  Michael A. Singer, MD

  Updates from the Field

  2024